Literature DB >> 21145938

The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice.

Qing-Zhen Yang1, Song-Song Lu, Xiao-Zhu Tian, Ai-Min Yang, Wan-Wen Ge, Qiang Chen.   

Abstract

In the present study, we investigated the antidepressive activity of opiorphin with central administration in the forced swim test in mice. Intracerebroventricular (i.c.v.) administration of opiorphin (1-6 μg/mouse) dose-dependently decreased the immobility time, which was reversed by nonselective opioid receptor antagonist naloxone, δ-selective naltrindole and μ-selective β-FNA. The data suggested that central administration of opiorphin produced an antidepressant-like effect by activating both μ and δ opioid receptors indirectly. In order to eliminate the possibility of a false-positive result in the forced swim test, locomotor activity was checked in both non-habituated and habituated mice. Opiorphin had no influence on non-habituated mice, though had weak effect on habituated mice. In addition, mice treated with opiorphin did not display any convulsive behaviors. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145938     DOI: 10.1016/j.neulet.2010.12.002

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Opiorphin in burning mouth syndrome patients: a case-control study.

Authors:  Ivan Salarić; Maja Sabalić; Ivan Alajbeg
Journal:  Clin Oral Investig       Date:  2016-12-24       Impact factor: 3.573

Review 2.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

3.  Possible Involvement of µ Opioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats.

Authors:  Fu-Rong Wang; Ming-Qi Qiao; Ling Xue; Sheng Wei
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

4.  Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management.

Authors:  Natascia Mennini; Paola Mura; Cristina Nativi; Barbara Richichi; Lorenzo Di Cesare Mannelli; Carla Ghelardini
Journal:  Future Sci OA       Date:  2015-11-01

5.  The Coordination Abilities of Three Novel Analogues of Saliva Peptides: The Influence of Structural Modification on the Copper Binding.

Authors:  Aleksandra Kotynia; Edward Krzyżak; Elżbieta Kamysz; Małgorzata Sobocińska; Justyna Brasuń
Journal:  Int J Pept Res Ther       Date:  2017-02-04       Impact factor: 1.931

Review 6.  Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.

Authors:  Mervin Chávez-Castillo; Victoria Núñez; Manuel Nava; Ángel Ortega; Milagros Rojas; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Adv Pharmacol Sci       Date:  2019-01-03

7.  Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.

Authors:  Courtney M Cameron; Steven Nieto; Lucienne Bosler; Megan Wong; Isabel Bishop; Larissa Mooney; Catherine M Cahill
Journal:  Adv Drug Alcohol Res       Date:  2021-08-03

8.  Expression of salivary immunoglobulins and their association with analgesic neuropeptide opiorphin in anorexia nervosa during adolescence.

Authors:  Elzbieta Paszynska; Amadeusz Hernik; Agnieszka Slopien; Yves Boucher; Marta Tyszkiewicz-Nwafor; Magdalena Roszak; Karolina Bilska; Monika Dmitrzak-Weglarz
Journal:  J Eat Disord       Date:  2022-08-11

Review 9.  Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?

Authors:  Magdalena Mizerska-Dudka; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-06       Impact factor: 4.291

10.  Salivary Biomarkers (Opiorphin, Cortisol, Amylase, and IgA) Related to Age, Sex, and Stress Perception in a Prospective Cohort of Healthy Schoolchildren.

Authors:  Anna Krahel; Elzbieta Paszynska; Justyna Otulakowska-Skrzynska; Szymon Rzatowski; Amadeusz Hernik; Agnieszka Slopien; Tomasz Hanć; Paula Szczesniewska; Ewa Bryl; Yves Boucher; Marta Tyszkiewicz-Nwafor; Maria Gawriolek; Monika Dmitrzak-Weglarz
Journal:  Mediators Inflamm       Date:  2021-11-12       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.